Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2024Diabetes

933-P: Effects of Dapagliflozin and Metformin on Vascular Function in Newly Diagnosed Type 2 Diabetes—A Randomized Controlled Trial (DMVascular Study)

View Full Paper
Ask AI
Bookmark
Share

Authors

RDRinkoo DalanYCYING JIE CHEEXZXIAOE ZHANG

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dalan et al. (2024) studied this question.

synapsesocial.com/papers/68e64c4eb6db6435875dd25bhttps://doi.org/10.2337/db24-933-p
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1First‐Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial2026
  2. 2Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study2017 · 251 citations
  3. 3Effects of Dapagliflozin on Endothelial Dysfunction in Type 2 Diabetes With Established Ischemic Heart Disease (EDIFIED)2019 · 55 citations
  4. 4Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial2021 · 86 citations
  5. 5Influence of dapagliflozin on cardiovascular remodeling in hypertensive patients with accompanying type 2 diabetes2024